Edwards Lifesciences (EW) Tops Q1 EPS by 10c; Issues Mixed Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $88.40 +0.12%
Revenue Growth %: +8.4%
Financial Fact:
Selling, general and administrative expenses: 229.6M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Revenue Growth %: +8.4%
Financial Fact:
Selling, general and administrative expenses: 229.6M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Join SI Premium – FREE
Edwards Lifesciences (NYSE: EW) reported Q1 EPS of $1.22, $0.10 better than the analyst estimate of $1.12. Revenue for the quarter came in at $938 million versus the consensus estimate of $932.25 million.
GUIDANCE:
Edwards Lifesciences sees FY2018 EPS of $4.50-$4.70, versus the consensus of $4.54.
Edwards Lifesciences sees FY2018 EPS of $1.05-$1.15, versus the consensus of $1.17.
For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Liberty Oilfield Services (LBRT) Misses Q3 EPS by 1c
- Kaiser Aluminum (KALU) Misses Q3 EPS by 48c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
